Podcasts

Share

Program Content

Activities

  • CLL BTKi Therapy: FAQ Part 2
    Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 16, 2020

    Expires: September 15, 2021

  • CLL BTKi Therapy: FAQ Part 1
    Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 17, 2020

    Expires: September 16, 2021

  • CLL BTKi Therapy: FAQ Part 3
    Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 17, 2020

    Expires: September 16, 2021

Faculty

cover img faculity

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

Provided by

ProCE Banner

Supporters

AstraZeneca